These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19036883)

  • 1. Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes.
    Grozovsky R; Ribich S; Rosene ML; Mulcahey MA; Huang SA; Patti ME; Bianco AC; Kim BW
    Endocrinology; 2009 Apr; 150(4):1976-83. PubMed ID: 19036883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor-γ coactivator-1α expression in skeletal muscle.
    Bocco BM; Louzada RA; Silvestre DH; Santos MC; Anne-Palmer E; Rangel IF; Abdalla S; Ferreira AC; Ribeiro MO; Gereben B; Carvalho DP; Bianco AC; Werneck-de-Castro JP
    J Physiol; 2016 Sep; 594(18):5255-69. PubMed ID: 27302464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid Hormone Signaling in Male Mouse Skeletal Muscle Is Largely Independent of D2 in Myocytes.
    Werneck-de-Castro JP; Fonseca TL; Ignacio DL; Fernandes GW; Andrade-Feraud CM; Lartey LJ; Ribeiro MB; Ribeiro MO; Gereben B; Bianco AC
    Endocrinology; 2015 Oct; 156(10):3842-52. PubMed ID: 26214036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Global Loss of Dio2 Leads to Unexpected Changes in Function and Fiber Types of Slow Skeletal Muscle in Male Mice.
    Carmody C; Ogawa-Wong AN; Martin C; Luongo C; Zuidwijk M; Sager B; Petersen T; Roginski Guetter A; Janssen R; Wu EY; Bogaards S; Neumann NM; Hau K; Marsili A; Boelen A; Silva JE; Dentice M; Salvatore D; Wagers AJ; Larsen PR; Simonides WS; Zavacki AM
    Endocrinology; 2019 May; 160(5):1205-1222. PubMed ID: 30951174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PPAR gamma agonist troglitazone induces musclin mRNA expression in human myotubes.
    Staiger H; Haas C; Machicao F; Häring HU
    Horm Metab Res; 2006 Sep; 38(9):614-6. PubMed ID: 16981146
    [No Abstract]   [Full Text] [Related]  

  • 6. Palmitate-induced down-regulation of sortilin and impaired GLUT4 trafficking in C2C12 myotubes.
    Tsuchiya Y; Hatakeyama H; Emoto N; Wagatsuma F; Matsushita S; Kanzaki M
    J Biol Chem; 2010 Nov; 285(45):34371-81. PubMed ID: 20805226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscle.
    Marsili A; Tang D; Harney JW; Singh P; Zavacki AM; Dentice M; Salvatore D; Larsen PR
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E818-24. PubMed ID: 21771965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity.
    Marsili A; Aguayo-Mazzucato C; Chen T; Kumar A; Chung M; Lunsford EP; Harney JW; Van-Tran T; Gianetti E; Ramadan W; Chou C; Bonner-Weir S; Larsen PR; Silva JE; Zavacki AM
    PLoS One; 2011; 6(6):e20832. PubMed ID: 21698184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Developmental Disruption of Type 2 Deiodinase Pathway in Mouse Skeletal Muscle Does Not Impair Muscle Function.
    Ignacio DL; Silvestre DH; Anne-Palmer E; Bocco BM; Fonseca TL; Ribeiro MO; Gereben B; Bianco AC; Werneck-de-Castro JP
    Thyroid; 2017 Apr; 27(4):577-586. PubMed ID: 27967605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Type 2 Deiodinase-Dependent Increase in
    An X; Ogawa-Wong A; Carmody C; Ambrosio R; Cicatiello AG; Luongo C; Salvatore D; Handy DE; Larsen PR; Wajner SM; Dentice M; Zavacki AM
    Thyroid; 2021 Jan; 31(1):115-127. PubMed ID: 32787533
    [No Abstract]   [Full Text] [Related]  

  • 11. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.
    Yao-Borengasser A; Rassouli N; Varma V; Bodles AM; Rasouli N; Unal R; Phanavanh B; Ranganathan G; McGehee RE; Kern PA
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4431-9. PubMed ID: 18697866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis.
    Hall JA; Ribich S; Christoffolete MA; Simovic G; Correa-Medina M; Patti ME; Bianco AC
    Endocrinology; 2010 Sep; 151(9):4573-82. PubMed ID: 20660060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development.
    Galton VA; Wood ET; St Germain EA; Withrow CA; Aldrich G; St Germain GM; Clark AS; St Germain DL
    Endocrinology; 2007 Jul; 148(7):3080-8. PubMed ID: 17332058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism.
    Marsili A; Ramadan W; Harney JW; Mulcahey M; Castroneves LA; Goemann IM; Wajner SM; Huang SA; Zavacki AM; Maia AL; Dentice M; Salvatore D; Silva JE; Larsen PR
    Endocrinology; 2010 Dec; 151(12):5952-60. PubMed ID: 20881246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-gamma activation in +db/+m and +db/+db mice.
    Seto SW; Lam TY; Leung GP; Au AL; Ngai SM; Chan SW; Kwan YW
    Eur J Pharmacol; 2007 Oct; 572(1):40-8. PubMed ID: 17603034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4.
    Schneider MJ; Fiering SN; Pallud SE; Parlow AF; St Germain DL; Galton VA
    Mol Endocrinol; 2001 Dec; 15(12):2137-48. PubMed ID: 11731615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific inactivation of type 2 deiodinase reveals multilevel control of fatty acid oxidation by thyroid hormone in the mouse.
    Fonseca TL; Werneck-De-Castro JP; Castillo M; Bocco BM; Fernandes GW; McAninch EA; Ignacio DL; Moises CC; Ferreira AR; Gereben B; Bianco AC
    Diabetes; 2014 May; 63(5):1594-604. PubMed ID: 24487027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.
    Chintalgattu V; Harris GS; Akula SM; Katwa LC
    Cardiovasc Res; 2007 Apr; 74(1):140-50. PubMed ID: 17320065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of type 2 deiodinase in response to acute lung injury (ALI) in mice.
    Barca-Mayo O; Liao XH; DiCosmo C; Dumitrescu A; Moreno-Vinasco L; Wade MS; Sammani S; Mirzapoiazova T; Garcia JG; Refetoff S; Weiss RE
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1321-9. PubMed ID: 22065740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-2 iodothyronine 5'deiodinase (D2) in skeletal muscle of C57Bl/6 mice. II. Evidence for a role of D2 in the hypermetabolism of thyroid hormone receptor alpha-deficient mice.
    Ramadan W; Marsili A; Larsen PR; Zavacki AM; Silva JE
    Endocrinology; 2011 Aug; 152(8):3093-102. PubMed ID: 21652727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.